Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc

Registered Charity 3104


Mailing address:

PO Box 322,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (PDF, 156KB)
Why become a member?

Cognitive Dysfunction In Chronic Fatigue Syndrome, Molecular Pattern Discovered

Thursday 12 January 2017


From Bel Marra Health:



Cognitive dysfunction in chronic fatigue syndrome, molecular pattern discovered, hopes for improved diagnosis and treatment

By Devon Andre
Monday, January 09, 2017
Copyright © 2017 BelMarraHealth. All Rights Reserved.

A molecular pattern has been discovered with regards to cognitive dysfunction in chronic fatigue syndrome, giving hope for improved diagnosis and treatment. The researchers uncovered a unique pattern of immune molecules in the cerebrospinal fluid in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This discovery provides insight into the basis for cognitive dysfunction – also known as brain fog – and may inform advancements in the syndrome diagnosis and treatment.

The researchers measured the levels of 51 immune biomarkers called cytokines in cerebrospinal fluid of 32 ME/CFS patients, 40 multiple sclerosis patients, and 19 healthy controls. The researchers found that the levels of most cytokines were depressed in ME/CFS patients, compared to the other groups.


Full article…



blog comments powered by Disqus
Previous Previous Page